Growth Metrics

BioCorRx (BICX) Amortization of Deferred Charges (2015 - 2025)

BioCorRx recorded quarterly Amortization of Deferred Charges of $1877.0 in Q4 2025, down 96.33% quarter-over-quarter from $51198.0 in Q1 2025, and down 98.15% year-over-year from $101725.0 in Q4 2024.

BioCorRx's Amortization of Deferred Charges history runs 5 years deep, the most recent figure standing at $1877.0 for Q4 2025.

  • In Q4 2025, Amortization of Deferred Charges fell 98.15% year-over-year to $1877.0; the TTM figure through Mar 2026 stood at $154800.0 (up 1.23% YoY), while the FY2025 annual figure was $55738.0, down 91.03% from the prior year.
  • Amortization of Deferred Charges came in at $1877.0 for Q4 2025 at BioCorRx, down from $51198.0 in the prior quarter.
  • In the past five years, Amortization of Deferred Charges ranged from a high of $101725.0 in Q4 2024 to a low of $1877.0 in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 84.64 Bn 87.02 Bn 16.26 Bn
2 Tenet Healthcare 15.22 Bn 14.39 Bn 4.41 Bn
3 Davita 13.10 Bn 13.96 Bn 1.07 Bn
4 Encompass Health 10.50 Bn 11.12 Bn 1.34 Bn
5 Ensign 9.69 Bn 9.09 Bn 293.37 Mn
6 Universal Health Services 8.92 Bn 8.88 Bn 3.21 Bn
7 Fresenius Medical Care AG 7.31 Bn 4.93 Bn 22,843.10 Bn
8 Chemed 5.83 Bn 5.81 Bn 215.76 Mn
9 Pacs 5.76 Bn 5.51 Bn 345.96 Mn
10 BioCorRx - - 189,355.00

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 1,877.00
Dec 31, 2025 1,877.00
Dec 31, 2024 101,725.00
Dec 31, 2024 101,725.00
Mar 31, 2017 9.36 Mn
Mar 31, 2017 9.36 Mn
Dec 31, 2016 45,152.00
Dec 31, 2016 45,152.00
Mar 31, 2016 21,722.00
Mar 31, 2016 21,722.00
Dec 31, 2015 35,488.00
Dec 31, 2015 35,488.00
Sep 30, 2015 48,234.00
Sep 30, 2015 48,234.00
Jun 30, 2015 14,966.00
Jun 30, 2015 14,966.00
Mar 31, 2015 71,354.00
Mar 31, 2015 71,354.00